Boehringer Ingelheim Vetera Gold XP [10 Dose]
Boehringer Ingelheim Vetera Gold XP [10 Dose]
VETERA GOLDXP has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against: Eastern and western encephalomyelitis (EEE & WEE), West nile virus (WNV), Tetanus, respiratory disease due to equine herpes virus types 1 and 4 (EHV-1 & EHV-4), and Equine influenza virus (EIV). VETERA® GOLDXP has also been shown to be effective against viral shedding due to A2 EIV and against viremia, mortality, and neurological clinical disease due to WNV. The VETERA® portfolio features a wide range of progressive choices and contains the most comprehensive 1 mL vaccine (VETERA® GOLDXP + VEE) on the US market. VETERA® was the first vaccine in the US updated to contain both Florida sublineage clade 1 and clade 2 EIV, as recommended by the Expert Surveillance Panel (OIE) on Equine Influenza and AAEP.
Shake well before use. Using aseptic technique, inoculate horses intramuscularly (IM) with a 1 mL dose. Administer a second 1mL dose intramuscularly in 3-4 weeks using a different injection site.
Boehringer Ingelheim Vetera Gold XP
- Manufacturer: Boehringer Ingelheim
- SKU: 22395
-
7-way protection in one vaccine
-
Carbimmune® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
-
Ultrafil® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
-
At least 6-month duration of immunity against EIV (OH/03)
-
At least 12-month WNV duration of immunity
-
Safe for use in horses as young as 4 months of age, including pregnant mares
| Species | Equine |
|---|---|
| Waterproof | No |
| Safety Toe | No |
| Dose | 10 DS |
| ORMD | No |
| Case Quantity | 10 |
| Unit of Measure | each |
| Hazardous | No |